Georgetown Lombardi Comprehensive Cancer Center: Innovative Steps Toward Individualized Treatment
Established in 1970 as a small clinic for cancer patients, the Georgetown Lombardi Comprehensive Cancer Center was named for football coach Vince Lombardi, who was treated for cancer at Georgetown University Hospital.
Denosumab Has Lower NNT Versus Zoledronic Acid for Prevention of SREs
Fewer cancer patients need to be treated with denosumab to prevent one skeletal-related event due to bone metastases from solid tumors.
Flaxseed Ineffective in Controlling Hot Flashes
Flaxseed had no effect on reducing hot flashes in postmenopausal women who reported experiencing 28 or more hot flashes per week.
Value-Based Coverage Decisions: CMS Scrutinizes Provenge
In late March, CMS ended the speculation by announcing its intention to pay for onlabel uses of the drug, which costs $93,000 for a 3-dose regimen, while leaving off-label coverage decisions to its regional contractors.
ASCO Highlights: Trials in Progress
The following is a roundup of TPS abstracts that feature trials open to patients aged >17 years with a broad range of cancer types.
Clinicians Need to Coordinate More Effectively in Cancer Survivorship Care
A survey of more than 2200 physicians indicated that cancer specialists and primary care physicians (PCPs) differ markedly in their concerns about the care that cancer survivors receive.
Bristol-Myers Squibb Agrees to Purchase Amira Pharmaceuticals
Bristol-Myers Squibb has agreed to purchase Amira Pharmaceuticals, a privately held biotech company, for $325 million and potential additional milestone payments of $150 million.
Investigational Agent Provides Hope for Patients With Myelofibrosis
Treating myelofibrosis with the investigational JAK inhibitor ruxolitinib holds promise.
Recognizing a Need for Psychiatrists in Cancer Hospitals
Dr Jimmie C. Holland was long convinced that psychological status was a critical factor not just in cancer management, but in illness more broadly.
State of Mind? Assessing the Psychosocial Needs of Patients With Cancer
Oncologists too often fail to detect the severe distress that can accompany a diagnosis and subsequent treatment.
Quality-of-Life Targeted Therapies
In the context of caring for cancer patients, all physicians and nurses trained in oncology receive education in quality-of-life issues; however, prolonging quantity of life remains our ultimate goal.
Sotigalimab/Pembrolizumab Combo Continues to Show Clinical Activity in Frontline Melanoma
Dr. Halmos on Trastuzumab Deruxtecan in NSCLC
Dr. Kris on Immunotherapy in NSCLC Without Driver Mutations
Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.